Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D William Cameron

Showing results (71-80 of 98) with videos related to

Pageof 10
Sort By:
Journal of Immunology Research|December 1, 2025
Failure of γδ T Cell Recovery in the Gut With Effective Anti-HIV TherapyPriscila O Barros, Stephanie C Burke Schinkel, Ameeta Lubina Nayak, et al.
The Journal of Antimicrobial Chemotherapy|March 14, 2007
Exploratory study comparing the metabolic toxicities of a lopinavir/ritonavir plus saquinavir dual protease inhibitor regimen versus a lopinavir/ritonavir plus zidovudine/lamivudine nucleoside regimenD William Cameron, Stephen Becker, Martin S King, et al.
International Journal of Environmental Research and Public Health|August 28, 2025
Mental Health and Cognitive Outcomes in Patients Six Months After Testing Positive Compared with Matched Patients Testing Negative for COVID-19 in a Non-Hospitalized Sample: A Matched Retrospective Cohort StudyBrooklyn Ward, Nicole E Edgar, Chloe Ahluwalia, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 2, 2002
Field evaluation of the Merlin immediate HIV-1 and -2 test for point-of-care detection of human immunodeficiency virus antibodiesStephen D Shafran, Brian Conway, Errol Prasad, et al.
AIDS (London, England)|August 23, 2018
Breastfeeding mitigates the effects of maternal HIV on infant infectious morbidity in the Option B+ eraChristophe Toukam Tchakoute, Kristin Lynn Sainani, Sophia Osawe, et al.
Plos One|March 27, 2014
The VACS index accurately predicts mortality and treatment response among multi-drug resistant HIV infected patients participating in the options in management with antiretrovirals (OPTIMA) studySheldon T Brown, Janet P Tate, Tassos C Kyriakides, et al.
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|April 20, 2011
Inhibition of human cytochrome p450 metabolism by blended herbal products and vitaminsTeresa W Tam, Humayoun Akhtar, John Thor Arnason, et al.
Plos One|July 18, 2014
Taima (stop) TB: the impact of a multifaceted TB awareness and door-to-door campaign in residential areas of high risk for TB in Iqaluit, NunavutGonzalo G Alvarez, Deborah D VanDyk, Shawn D Aaron, et al.
AIDS (London, England)|June 5, 2002
Normalization of natural killer cell function and phenotype with effective anti-HIV therapy and the role of IL-10Karl G Parato, Ashok Kumar, Andrew D Badley, et al.
BMJ Open|October 9, 2020
Vedolizumab treatment across antiretroviral treatment interruption in chronic HIV infection: the HAVARTI protocol for a pilot dose-ranging clinical trial to assess safety, tolerance, immunological and virological activityMichaeline McGuinty, Jonathan B Angel, Curtis L Cooper, et al.
Pageof 10

Showing results (71-80 of 98) with videos related to

Sort By:
Pageof 10
Journal of Immunology Research|December 1, 2025
Failure of γδ T Cell Recovery in the Gut With Effective Anti-HIV TherapyPriscila O Barros, Stephanie C Burke Schinkel, Ameeta Lubina Nayak, et al.
The Journal of Antimicrobial Chemotherapy|March 14, 2007
Exploratory study comparing the metabolic toxicities of a lopinavir/ritonavir plus saquinavir dual protease inhibitor regimen versus a lopinavir/ritonavir plus zidovudine/lamivudine nucleoside regimenD William Cameron, Stephen Becker, Martin S King, et al.
International Journal of Environmental Research and Public Health|August 28, 2025
Mental Health and Cognitive Outcomes in Patients Six Months After Testing Positive Compared with Matched Patients Testing Negative for COVID-19 in a Non-Hospitalized Sample: A Matched Retrospective Cohort StudyBrooklyn Ward, Nicole E Edgar, Chloe Ahluwalia, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 2, 2002
Field evaluation of the Merlin immediate HIV-1 and -2 test for point-of-care detection of human immunodeficiency virus antibodiesStephen D Shafran, Brian Conway, Errol Prasad, et al.
AIDS (London, England)|August 23, 2018
Breastfeeding mitigates the effects of maternal HIV on infant infectious morbidity in the Option B+ eraChristophe Toukam Tchakoute, Kristin Lynn Sainani, Sophia Osawe, et al.
Plos One|March 27, 2014
The VACS index accurately predicts mortality and treatment response among multi-drug resistant HIV infected patients participating in the options in management with antiretrovirals (OPTIMA) studySheldon T Brown, Janet P Tate, Tassos C Kyriakides, et al.
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|April 20, 2011
Inhibition of human cytochrome p450 metabolism by blended herbal products and vitaminsTeresa W Tam, Humayoun Akhtar, John Thor Arnason, et al.
Plos One|July 18, 2014
Taima (stop) TB: the impact of a multifaceted TB awareness and door-to-door campaign in residential areas of high risk for TB in Iqaluit, NunavutGonzalo G Alvarez, Deborah D VanDyk, Shawn D Aaron, et al.
AIDS (London, England)|June 5, 2002
Normalization of natural killer cell function and phenotype with effective anti-HIV therapy and the role of IL-10Karl G Parato, Ashok Kumar, Andrew D Badley, et al.
BMJ Open|October 9, 2020
Vedolizumab treatment across antiretroviral treatment interruption in chronic HIV infection: the HAVARTI protocol for a pilot dose-ranging clinical trial to assess safety, tolerance, immunological and virological activityMichaeline McGuinty, Jonathan B Angel, Curtis L Cooper, et al.
Pageof 10